BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegra A, Tonacci A, Musolino C, Pioggia G, Gangemi S. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Front Immunol 2021;12:738915. [PMID: 34759921 DOI: 10.3389/fimmu.2021.738915] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Sasaki J, Tominaga M, Sudou M, Tokisawa S, Nishii Y, Zaizen Y, Matama G, Chikasue T, Fujimoto K, Tabata K, Fukuoka J, Takemura T, Kawayama T, Hoshino T. Granulomatous Lymphocytic Interstitial Lung Disease in Multiple Myeloma. Intern Med 2023;62:439-44. [PMID: 35831114 DOI: 10.2169/internalmedicine.9758-22] [Reference Citation Analysis]
2 Bozorgmehr N, Hnatiuk M, Peters AC, Elahi S. Depletion of polyfunctional CD26(high)CD8(+) T cells repertoire in chronic lymphocytic leukemia. Exp Hematol Oncol 2023;12:13. [PMID: 36707896 DOI: 10.1186/s40164-023-00375-5] [Reference Citation Analysis]
3 Cheng YD, Huang CH, Gau SY, Chung NJ, Huang SW, Huang CY, Lee CY. Risk of Pneumocystis jirovecii Pneumonia among Solid Organ Transplant Recipients: A Population-Based Study. J Fungi (Basel) 2022;9. [PMID: 36675844 DOI: 10.3390/jof9010023] [Reference Citation Analysis]
4 Yang Y, Shu Y, Chen G, Yin Y, Li F, Li J. A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax. PLoS One 2022;17:e0278725. [PMID: 36477747 DOI: 10.1371/journal.pone.0278725] [Reference Citation Analysis]
5 Jancar N, Sousa Gonçalves F, Duro J, Lessa Simões M, Aguiar P. Progressive Multifocal Leukoencephalopathy in a Chemotherapy-Naive Patient With Chronic Lymphocytic Leukemia: A Case Report. Cureus 2022;14:e32912. [PMID: 36699752 DOI: 10.7759/cureus.32912] [Reference Citation Analysis]
6 Allegra A, Mirabile G, Ettari R, Pioggia G, Gangemi S. The Impact of Curcumin on Immune Response: An Immunomodulatory Strategy to Treat Sepsis. Int J Mol Sci 2022;23. [PMID: 36499036 DOI: 10.3390/ijms232314710] [Reference Citation Analysis]
7 Ding Y, Shen Y, Fan Y, Chen J, Xu Y, Wu D. The safety and short-term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID-19. MedComm (2020) 2022;3:e179. [PMID: 36226252 DOI: 10.1002/mco2.179] [Reference Citation Analysis]
8 Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI Study Team. Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19. JAMA Oncol 2022. [PMID: 35951338 DOI: 10.1001/jamaoncol.2022.3227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi SA, Bashash D. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies. Int Immunopharmacol 2022;110:109046. [PMID: 35843148 DOI: 10.1016/j.intimp.2022.109046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Haggenburg S, Hofsink Q, Lissenberg-witte BI, Broers AE, van Doesum JA, van Binnendijk RS, Hartog GD, Bhoekhan MS, Haverkate NJ, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MH, Groen K, van Meerten T, Mutsaers PG, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients.. [DOI: 10.1101/2022.04.08.22273602] [Reference Citation Analysis]
11 Bangolo AI, Cherian J, Jandir P, Nasir Q, Lo A. Management of Newly Diagnosed Chronic Myeloid Leukemia During COVID-19 Hospitalization: A Teaching Case. Cureus 2022. [DOI: 10.7759/cureus.24093] [Reference Citation Analysis]
12 Naimi A, Yashmi I, Jebeleh R, Imani Mofrad M, Azimian Abhar S, Jannesar Y, Heidary M, Pakzad R. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis. J Clin Lab Anal 2022;:e24387. [PMID: 35385130 DOI: 10.1002/jcla.24387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]